Karol Pál
Impact in
-
- Chronic Lymphocytic Leukemia Research
-
- Lymphoma Diagnosis and Treatment
Papers in
-
- Lymphoma Diagnosis and Treatment 8
- Genetics 6
- Chronic Lymphocytic Leukemia Research 6
- Co-authors
- Šárka Pospı́šilová (9 shared papers)Lenka Radová (6 shared papers)Michael Doubek (6 shared papers)Jitka Malčíková (4 shared papers)Nikola Tom (4 shared papers)Jiřı́ Mayer (3 shared papers)Veronika Navrkalová (3 shared papers)Anna Panovská (3 shared papers)
- Journals
- HemaSphere (3 papers)Blood (3 papers)PeerJ (2 papers)Leukemia (2 papers)Bioinformatics (1 paper)
- Partner nations
- CzechiaGermanyUnited Kingdom
In The Last Decade
Karol Pál
20 papers receiving 163 citations
Peers
Comparison fields: 5 of 31
- Genetics 63
- Pathology and Forensic Medicine 64
- Hematology 20
- Cancer Research 26
- Oncology 36
Countries citing papers authored by Karol Pál
This map shows the geographic impact of Karol Pál's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karol Pál with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karol Pál more than expected).
Fields of papers citing papers by Karol Pál
This network shows the impact of papers produced by Karol Pál. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karol Pál. The network helps show where Karol Pál may publish in the future.
Co-authors
The 25 scholars most cited alongside Karol Pál, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 27 | |
| 2 | 2019 | 22 | |
| 3 | 2019 | 18 | |
| 4 | 2021 | 14 | |
| 5 | 2020 | 12 | |
| 6 | 2020 | 12 | |
| 7 | 2018 | 10 | |
| 8 | 2017 | 9 | |
| 9 | 2018 | 9 | |
| 10 | 2021 | 7 | |
| 11 | 2024 | 6 | |
| 12 | 2023 | 5 | |
| 13 | 2021 | 5 | |
| 14 | 2022 | 3 | |
| 15 | 2022 | 3 | |
| 16 | 2019 | 2 | |
| 17 | 2020 | 1 | |
| 18 | 2019 | 1 | |
| 19 | 2019 | 1 | |
| 20 | 2022 | 1 |
About Karol Pál
Karol Pál is a scholar working on Pathology and Forensic Medicine, Genetics, Cancer Research, Pulmonary and Respiratory Medicine and Oncology, having authored 22 papers that have together received 168 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (8 papers), Chronic Lymphocytic Leukemia Research (6 papers), Cancer Genomics and Diagnostics (5 papers), Viral-associated cancers and disorders (3 papers), Acute Lymphoblastic Leukemia research (2 papers), Immunodeficiency and Autoimmune Disorders (2 papers), Sarcoma Diagnosis and Treatment (1 paper) and Ubiquitin and proteasome pathways (1 paper). The work is most often cited by research in Genetics (63 citations), Pathology and Forensic Medicine (64 citations), Hematology (20 citations), Cancer Research (26 citations) and Oncology (36 citations). Karol Pál has collaborated with scholars based in Czechia, Germany and United Kingdom. Frequent co-authors include Šárka Pospı́šilová, Lenka Radová, Michael Doubek, Jitka Malčíková, Nikola Tom, Jiřı́ Mayer, Veronika Navrkalová, Anna Panovská, Šárka Pavlová and Jana Kotašková. Their work appears in journals such as HemaSphere, Blood, PeerJ, Leukemia and Bioinformatics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.